Laurent Ameye
Research Subjects
Laurent Ameye has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Carole Vaysse
Nutrition-Health & Lipid Biochemistry Department, ITERG, 33610 Canejan, France
3 shared publications - Claude Billeaud
Centre Hospitalier Universitaire de Bordeaux
3 shared publications - Cristina Cruz-Hernandez
Nestlé Research Centre, 1000 Lausanne, Switzerland
3 shared publications - Elie Saliba
Department of Dermatology , Gilbert and Rose-Marie Chagoury School of Medicine , Lebanese American University , Byblos , Lebanon , lau.edu.lb
3 shared publications - Frédéric Destaillats
Nestlé Nutrition R&D, 1800 Vevey, Switzerland
3 shared publications - Jacques Rigo
Department of Neonatology, University of Liège, 4000 Liège, Belgium
3 shared publications
Latest Publications
- Open Access
- 23 April 2025
- Published by Elsevier in Current Research in Food Science
- Vol. 10, 101055
Stability of nutrients in complex liquid and powder food matrices: learnings from shelf-life studies in foods for special medical purposes
- 23 April 2025
- Published by Elsevier in Current Research in Food Science
- Vol. 10, 101055
Open AccessStability of nutrients in complex liquid and powder food matrices: learnings from shelf-life studies in foods for special medical purposes
- Open Access
Correction: Billeaud et al. “Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants” Nutrients 2018, 10, 690
The authors wish to make a correction to the published version of their paper
Open AccessCorrection: Billeaud et al. “Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants” Nutrients 2018, 10, 690
The authors wish to make a correction to the published version of their paper
- Open Access
Reply: “Letter to the Editor Re: Billeaud et al. Nutrients 2018, 10, 690”
We thank Bernard and colleagues for their careful reading and interest in our article Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants
Open AccessReply: “Letter to the Editor Re: Billeaud et al. Nutrients 2018, 10, 690”
We thank Bernard and colleagues for their careful reading and interest in our article Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants
- Open Access
Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants
Preterm infants require fortification of human milk (HM) with essential fatty acids (FA) to ensure adequate post-natal development. As part of a larger randomized controlled study, we investigated FA metabolism in a subset of 47 clinically stable preterm infants (birth weight ≤1500 g or gestational age ≤32 weeks). Infants were randomized to receive HM supplemented with either a new HM fortifier (nHMF; n = 26) containing 12.5 g medium-chain FA (MCFA), 958 mg linoleic acid (LA), 417 mg α-linolenic acid (ALA), and 157 mg docosahexaenoic acid (DHA) per 100 g of powder (in compliance with the latest guidelines) or a fat-free HMF (cHMF; n = 21). Plasma phospholipid (PL) and triacylglycerol (TAG), and red blood cell phosphatidylcholine (RBC-PC) and phosphatidylethanolamine (RBC-PE) FA profiles were assessed before and after 21 days of feeding. In the nHMF group, significantly increased levels of n-9 monounsaturated fatty acids were observed, formed most likely by elongation and desaturation of dietary saturated fatty acids present in HM. ALA fortification increased ALA assimilation into plasma TAG. Similarly, DHA fortification enriched the DHA content in RBC-PE, which, in this compartment, was not associated with lower arachidonic acid levels as observed in plasma TAG and phospholipids. RBC-PE, a reliable indicator of FA metabolism and accretion, was the most sensitive compartment in this study.
Open AccessEffects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants
Preterm infants require fortification of human milk (HM) with essential fatty acids (FA) to ensure adequate post-natal development. As part of a larger randomized controlled study, we investigated FA metabolism in a subset of 47 clinically stable preterm infants (birth weight ≤1500 g or gestational age ≤32 weeks). Infants were randomized to receive HM supplemented with either a new HM fortifier (nHMF; n = 26) containing 12.5 g medium-chain FA (MCFA), 958 mg linoleic acid (LA), 417 mg α-linolenic acid (ALA), and 157 mg docosahexaenoic acid (DHA) per 100 g of powder (in compliance with the latest guidelines) or a fat-free HMF (cHMF; n = 21). Plasma phospholipid (PL) and triacylglycerol (TAG), and red blood cell phosphatidylcholine (RBC-PC) and phosphatidylethanolamine (RBC-PE) FA profiles were assessed before and after 21 days of feeding. In the nHMF group, significantly increased levels of n-9 monounsaturated fatty acids were observed, formed most likely by elongation and desaturation of dietary saturated fatty acids present in HM. ALA fortification increased ALA assimilation into plasma TAG. Similarly, DHA fortification enriched the DHA content in RBC-PE, which, in this compartment, was not associated with lower arachidonic acid levels as observed in plasma TAG and phospholipids. RBC-PE, a reliable indicator of FA metabolism and accretion, was the most sensitive compartment in this study.